RESULTS
ADVERSE EFFECTS
The demographic characteristics of the enrolled women are presented in Demographic characteristics of participantsn: number of cases, SD: standard deviation, IQR: inter-quartile range, I: independent samples t-test, M: Mann Whitney U test, NS: not significant, **: significant at p ≤ 0.01The mean HbA1c% and mean hormonal concentrations of Nifedipine and Sildenafil groups are presented in Comparison of HbA1c% and serum hormonal levels between Nifedipine and Sildenafil groupsn: number of cases, SD: standard deviation, I: independent samples t-test, NS: not significantThe ultrasound findings of the Nifedipine and Sildenafil groups are presented in Comparison of ultrasound characteristics between Nifedipine and Sildenafil groupsn: number of cases, SD: standard deviation, I: independent samples t-test, NS: not significant, *: significant at p≤0.05, ***: significant at p≤0.001, a: the results of paired t-test was that p<0.001Regarding the resistive index, there was a significant variation in average baseline readings between enrolled categories, 0.98±0.14 At baseline, the mean endometrial thickness of the Nifedipine group was significantly lower than that of the Sildenafil group, 6.57±0.67 mm The rates of adverse effects in the Nifedipine and Sildenafil groups are presented in Rates of adverse effects in the Nifedipine and Sildenafil groupsn: number of cases, C: chi-square test; Y, Yates correction for continuity test, NS: not significant